To control for STEAP1 expression in an isogenic manner, we focused on the 22Rv1 human prostate cancer cell line that demonstrates native STEAP1 expression and performed STEAP1 knockout (ko) by CRISPR/Cas9 genome editing. This evidence concerns the gene STEAP1 and prostate cancer.